Paul A Leighton
Overview
Explore the profile of Paul A Leighton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leighton P, Darby J, Allen F, Cook M, Evley R, Fox C, et al.
Age Ageing
. 2022 Dec;
51(12).
PMID: 36469088
Background: falls in care homes are common, costly and hard to prevent.Multifactorial falls programmes demonstrate clinical and cost-effectiveness, but the heterogeneity of the care home sector is a barrier to...
2.
Leighton P, Brealey S, Dias J
Bone Jt Open
. 2022 Aug;
3(8):641-647.
PMID: 35968557
Aims: To explore individuals' experience of a scaphoid waist fracture and its subsequent treatment. Methods: A purposive sample was created, consisting of 49 participants in the Scaphoid Waist Internal Fixation...
3.
Herbert S, Rowbotham N, Smith S, Wilson P, Elliott Z, Leighton P, et al.
Thorax
. 2021 Sep;
77(3):295-297.
PMID: 34556553
Reducing treatment burden in cystic fibrosis (CF) is the top research priority for patients and clinicians. Difficulty accessing medication is one aspect of treatment burden. We investigated this with an...
4.
Calthorpe R, Smith S, Rowbotham N, Leighton P, Davies G, Daniels T, et al.
BMJ Open Respir Res
. 2020 Aug;
7(1).
PMID: 32816834
Introduction: "What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?" was identified as one of the James Lind Alliance Priority...
5.
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Davies G, Rowbotham N, Smith S, Elliot Z, Gathercole K, Rayner O, et al.
J Cyst Fibros
. 2019 Nov;
19(3):499-502.
PMID: 31735561
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: "What are effective ways of simplifying the treatment burden of...
6.
Leighton P, Brealey S, Dias J
J Evid Based Med
. 2018 Jan;
11(1):12-19.
PMID: 29356437
Objective: To explore stakeholder perspectives upon participant retention in clinical trials, and to generate strategies to support retention in a surgical, clinical trial. Study Design And Setting: The SWIFFT trial...
7.
Rowbotham N, Smith S, Leighton P, Rayner O, Gathercole K, Elliott Z, et al.
Thorax
. 2017 Aug;
73(4):388-390.
PMID: 28778919
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research should focus on questions which are most important to the CF community. We conducted a James Lind...
8.
Palser S, Rayner O, Leighton P, Smyth A
BMJ Open
. 2016 Dec;
6(12):e012303.
PMID: 28031208
Background: People with cystic fibrosis (CF) are susceptible to respiratory infection with Pseudomonas aeruginosa (PA), which may become chronic if initial eradication fails. Environmental acquisition and person-to-person transmission can occur....